Fertility and Sterility
Volume 91, Issue 3 , Pages 659-663 , March 2009

Return to fertility following discontinuation of oral contraceptives

  • Kurt T. Barnhart, M.D., M.S.C.E.

      Affiliations

    • Corresponding Author InformationReprint requests: Kurt T. Barnhart, M.D., Hospital of the University of Pennsylvania, Department of Obstetrics and Gynecology, 3701 Market St., 8th floor, Philadelphia, PA19104 (TEL: 215-662-2951; FAX: 215-349-5512).
    • ,
  • Courtney A. Schreiber, M.D., M.P.H.

Received 6 March 2008 ,Accepted 6 January 2009.

References 

  1. Hassan MA, Killick SR. Is previous use of hormonal contraception associated with a detrimental effect on subsequent fecundity?. Hum Reprod. 2004;19:344–351
  2. Kaplan B, Nahum R, Yairi Y, Hirsch M, Pardo J, Yogev Y, et al. Use of various contraceptive methods and time of conception in a community-based population. Eur J Obstet Gynecol Reprod Biol. 2005;123:72–76
  3. McIver B, Romanski SA, Nippoldt TB. Evaluation and management of amenorrhea. Mayo Clin Proc. 1997;72:1161–1169
  4. Whitelaw MJ, Nola VF, Kalman CF. Irregular menses, amenorrhea, and infertility following synthetic progestational agents. J Am Med Assoc. 1966;195:780–782
  5. Shearman RP. Amenorrhea after treatment with oral contraceptives. Lancet. 1966;2:1110–1111
  6. Horowitz BJ, Solomkin M, Edelstein SW. The oversuppression syndrome. Obstet Gynecol. 1968;31:387–389
  7. Halbert DR, Christian CD. Amenorrhea following oral contraceptives. Obstet Gynecol. 1969;34:161–167
  8. MacLeod SC, Parker AS, Perlin IA. The oversuppression syndrome. Am J Obstet Gynecol. 1970;106:359–364
  9. Archer DF, Thomas RL. The fallacy of the postpill amenorrhea syndrome. Clin Obstet Gynecol. 1981;24:943–950
  10. Speroff L, Fritz M. Clinical gynecologic endocrinology and infertility. 7th ed.. Baltimore, MD: Lippincott Williams and Wilkins; 2004;
  11. Tolis G, Ruggere D, Popkin DR, Chow J, Boyd ME, De Leon A, et al. Prolonged amenorrhea and oral contraceptives. Fertil Steril. 1979;32:265–268
  12. Buttram VC, Vanderheyden JD, Besch PK, Acosta AA. Post “pill” amenorrhoea. Int J Fertil. 1974;19:37–44
  13. Hitchcock CL, Prior JC. Evidence about extending the duration of oral contraceptive use to suppress menstruation. Womens Health Issues. 2004;14:201–211
  14. Institut national d'études démographiques. Teaching kit: waiting time to conception. Available at: http://www.ined.fr/fichier/t_telechargement/5587/telechargement_fichier_en_conceptionpdf.pdf. Accessed November 6, 2007.
  15. Hammond CB, Stillman RJ. Infertility and assisted reproduction. In:  Scott JR,  Di Saia P,  Hammond CB,  Spellacy W editor. Danforth's obstetrics and gynecology. Philadelphia, PA: Lippincott Williams and Wilkins; 1999;p. 649–668
  16. Vessey MP, Wright NH, McPherson K, Wiggins P. Fertility after stopping different methods of contraception. Br Med J. 1978;1:265–267
  17. Linn S, Schoenbaum SC, Monson RR, Rosner B, Ryan KJ. Delay in conception for former ‘pill’ users. J Am Med Assoc. 1982;247:629–632
  18. Harlap S, Baras M. Conception-waits in fertile women after stopping oral contraceptives. Int J Fertil. 1984;29:73–80
  19. Chasan-Taber L, Willett WC, Stampfer MJ, Spiegelman D, Rosner BA, Hunter DJ, et al. Oral contraceptives and ovulatory causes of delayed fertility. Am J Epidemiol. 1997;146:258–265
  20. Huggins GR, Cullins VE. Fertility after contraception or abortion. Fertil Steril. 1990;54:559–573
  21. Doll H, Vessey M, Painter R. Return of fertility in nulliparous women after discontinuation of the intrauterine device: comparison with women discontinuing other methods of contraception. BJOG. 2001;108:304–314
  22. Bracken MB, Hellenbrand KG, Holford TR. Conception delay after oral contraceptive use: the effect of estrogen dose. Fertil Steril. 1990;53:21–27
  23. Hassan J, Kulenthran A, Thum YS. The return of fertility after discontinuation of oral contraception in Malaysian women. Med J Malaysia. 1994;49:348–350
  24. Farrow A, Hull MG, Northstone K, Taylor H, Ford WC, Golding J. Prolonged use of oral contraception before a planned pregnancy is associated with a decreased risk of delayed conception. Hum Reprod. 2002;17:2754–2761
  25. Wiegratz I, Mittmann K, Dietrich H, Zimmermann T, Kuhl H. Fertility after discontinuation of treatment with an oral contraceptive containing 30 microg of ethinyl estradiol and 2 mg of dienogest. Fertil Steril. 2006;85:1812–1819
  26. Pardthaisong T, Gray RH, McDaniel EB. Return of fertility after discontinuation of depot medroxyprogesterone acetate and intra-uterine devices in Northern Thailand. Lancet. 1980;1:509–512
  27. Affandi B, Santoso SS, Djajadilaga , Hadisaputra W, Moeloek FA, Prihartono J, et al. Pregnancy after removal of Norplant implants contraceptive. Contraception. 1987;36:203–209
  28. Andersson K, Batar I, Rybo G. Return to fertility after removal of a levonorgestrel-releasing intrauterine device and Nova-T. Contraception. 1992;46:575–584
  29. Pyorala T, Allonen H, Nygren KG, Nielsen NC, Luukkainen T. Return of fertility after the removal of Nova T or copper T 200. Contraception. 1982;26:113–120
  30. Skjeldestad FE, Bratt H. Return of fertility after use of IUDs (Nova-T, MLCu250 and MLCu375). Adv Contracept. 1987;3:139–145
  31. Soeprono R. Return to fertility after discontinuation of copper IUD use: a study of 55 pregnancies involving Multiload Cu-250 users among private patients in Indonesia. Adv Contracept. 1988;4:95–107
  32. Gupta BK, Gupta AN, Lyall S. Return of fertility in various types of IUD users. Int J Fertil. 1989;34:123–125
  33. Tadesse E. Return of fertility after an IUD removal for planned pregnancy: a six year prospective study. East Afr Med J. 1996;73:169–171
  34. Delbarge W, Batar I, Bafort M, Bonnivert J, Colmant C, Dhont M, et al. Return to fertility in nulliparous and parous women after removal of the GyneFix intrauterine contraceptive system. Eur J Contracept Reprod Health Care. 2002;7:24–30
  35. Henzl MR, Polan ML. Avoiding menstruation: a review of health and lifestyle issues. J Reprod Med. 2004;49:162–174
  36. Kaunitz AM. Menstruation: choosing whether…and when. Contraception. 2000;62:277–284
  37. Edelman AB, Gallo M, Jensen J, Nichols M, Schulz K, Grimes D. Continuous or extended cycle vs. cyclic use of combined oral contraceptives for contraception. Cochrane Database Syst Rev. 2005;3:CD004695
  38. Miller L, Notter KM. Menstrual reduction with extended use of combination oral contraceptive pills: randomized controlled trial. Obstet Gynecol. 2001;98:771–778
  39. Loudon NB, Foxwell M, Potts DM, Guild AL, Short RV. Acceptability of an oral contraceptive that reduces the frequency of menstruation: the tri-cycle pill regimen. Br Med J. 1977;2:487–490
  40. Wiegratz I, Hommel HH, Zimmermann T, Kuhl H. Attitude of German women and gynecologists towards long-cycle treatment with oral contraceptives. Contraception. 2004;69:37–42
  41. Wiegratz I, Kuhl H. Long-cycle treatment with oral contraceptives. Drugs. 2004;64:2447–2462
  42. Andrist LC, Arias RD, Nucatola D, Kaunitz AM, Musselman BL, Reiter S, et al. Women's and providers' attitudes toward menstrual suppression with extended use of oral contraceptives. Contraception. 2004;70:359–363
  43. Barnhart K, Mirkin S, Grubb G, Constantine G. Return of fertility after cessation of a continuous oral contraceptive. Fertil Steril. 2006;86:S15
  44. Archer DF, Jensen JT, Johnson JV, Borisute H, Grubb GS, Constantine GD. Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol: phase 3 study results. Contraception. 2006;74:439–445
  45. Davis AR, Kroll R, Soltes B, Zhang N, Grubb GS, Constantine GD. Occurrence of menses or pregnancy after cessation of a continuous oral contraceptive. Fertil Steril. 2008;89:1059–1063
  46. Archer DF, Kovalevsky G, Ballagh S, Grubb GS. Effect on ovarian activity of a continuous-use regimen of oral levonorgestrel/ethinyl estradiol. Fertil Steril. 2005;84(suppl 1):S24. Abstract O-57
  47. Craig L, Miller L, Criniti A. Rapid resumption of ovulation and menstruation following continuous use of the combination oral contraceptive. Fertil Steril. 2005;83:S16. Abstract P-8
  48. Singh K, Viegas OA, Ratnam SS. Menstrual changes during Norplant use and return of fertility following Norplant implant removal: the Singapore experience. Adv Contracept Deliv Syst. 1991;7:139–145
  49. Gnoth C, Godehardt D, Godehardt E, Frank-Herrmann P, Freundl G. Time to pregnancy: results of the German prospective study and impact on the management of infertility. Hum Reprod. 2003;18:1959–1966

 Supported by Wyeth Pharmaceuticals, Collegeville, PA. The authors were not compensated and retained full editorial control over the content of the manuscript.

 K.B. has served as a clinical trial investigator for Wyeth-Ayerst, Organon, Johnson & Johnson, Duramed, Xanodyne, Boehringer Ingelheim, Third Wave, Pfizer, and MGI Pharma; he has served as a consultant for Novo Nordisk and on the Speaker Bureau for Organon. C.A.S. has nothing to disclose.

PII: S0015-0282(09)00049-1

doi: 10.1016/j.fertnstert.2009.01.003

Fertility and Sterility
Volume 91, Issue 3 , Pages 659-663 , March 2009

Article Tools

* Image Usage & Resolution